- Home
- / Samsung Pharmaceutical
Samsung Pharmaceutical
Stock Price
₩1.6 K
2024-10-29
Market Capitalization
₩148.9 B
2024-10-29
Revenue
₩52 B
FY, 2023
Samsung Pharmaceutical Summary
Company Summary
- Overview
- Samsung Pharmaceutical (삼성제약(주) is a healthcare company that manufactures and sells pharmaceutical products. It offers OTC drinks and prescription medicines for anticancer immunotherapy, antipyretic analgesic, antiobesity, hypotensive, etc.
- Type
- Public
- Status
- Active
- Founded
- 1929
- HQ
- Hwaseong-si, KR | view all locations
- Website
- http://www.sspharm.co.kr
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Hwaseong-si, Gyeonggi-do HQ
Korea (Republic of)
Jeyakgongdan 4-gil, Hyangnam-eup
Samsung Pharmaceutical Financials
Summary Financials
- Revenue (Q3, 2024)
- ₩11.1B
- Gross profit (Q3, 2024)
- ₩4.4B
- Net income (Q3, 2024)
- ₩18.3B
- Cash (Q3, 2024)
- ₩20.2B
- EBIT (Q3, 2024)
- ₩18.2B
- Enterprise value
- $134.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026